|
Market Closed -
NYSE
21:00:02 17/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 309.41 USD | -2.85% |
|
-3.60% | -8.39% |
| 09-15 | Cencora, Inc. Presents at 2026 Global Healthcare Conference, Sep-15-2026 03:10 PM | |
| 09-15 | Cencora, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 08:30 AM |
| Market Cap | 59.04B 51.43B 48.67B 44.22B 82.61B 5,655B 83.02B 580B 224B 2,874B 222B 217B 9,200B | P/E 2026 * |
16.9x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 66.73B 58.13B 55.01B 49.98B 93.37B 6,391B 93.84B 655B 253B 3,248B 251B 245B 10,398B | EV / Sales 2026 * |
0.2x | EV / Sales 2027 * | 0.19x |
| Free-Float |
61.21% | Yield 2026 * |
0.77% | Yield 2027 * | 0.79% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
London S.E.
| 0HF3 | Delayed | |
|
Tradegate
| ABG | Real-time | |
|
Berne S.E.
| ABG | End-of-day quote | |
|
Wiener Boerse
| ABC | End-of-day quote | |
|
Boerse Muenchen
| ABG | Real-time | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | -2.85% | ||
| 1 week | -3.60% | ||
| Current month | -4.39% | ||
| 1 month | -1.00% | ||
| 3 months | +11.66% | ||
| 6 months | -7.56% | ||
| Current year | -8.39% |
| 1 week | 309.24 |  | 327.79 |
| 1 month | 309.24 | | 338.71 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 178.21 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.38 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 30/09/2024 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 28/06/2026 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 03/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 15/05/2013 |
Robert Mauch
BRD | Director/Board Member | 59 | 30/09/2024 |
D. Mark Durcan
CHM | Chairman | 64 | 30/09/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/09/26 | Sell | Director | -1,280 | 0.0007% | ||
| 01/09/26 | Sell | Controller/Auditor | -985 | 0.0005% | ||
| 24/08/26 | Sell | General Counsel | -11,300 | 0.0058% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.85% | -3.60% | +7.03% | +73.54% | 59.04B | |
| -0.13% | -1.09% | -23.81% | +0.48% | 177B | |
| +0.18% | +1.26% | -1.91% | +13.45% | 119B | |
| -0.26% | +2.81% | -3.30% | -31.23% | 49.41B | |
| -0.22% | -0.37% | +7.26% | +40.45% | 48.64B | |
| +0.68% | +4.05% | +15.03% | -8.74% | 33.18B | |
| -2.64% | -0.83% | - | - | 28.18B | |
| +1.27% | +6.49% | +42.85% | -7.00% | 25.8B | |
| +0.97% | +5.94% | +7.14% | -19.58% | 21.91B | |
| -2.33% | -0.36% | -11.58% | +3.49% | 21.69B | |
| Average | -0.54% | +1.58% | +4.30% | +7.21% | 58.34B | |
| Weighted average by Cap. | -0.45% | +0.44% | -4.18% | +10.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 294B 278B 253B 472B 32,291B 474B 3,311B 1,280B 16,411B 1,267B 1,238B 52,534B | 353B 308B 291B 264B 494B 33,818B 497B 3,467B 1,341B 17,187B 1,327B 1,297B 55,019B |
| Net income | 3.58B 3.12B 2.95B 2.68B 5.01B 343B 5.03B 35.15B 13.59B 174B 13.45B 13.15B 558B | 2.84B 2.48B 2.35B 2.13B 3.98B 272B 4B 27.93B 10.8B 138B 10.69B 10.45B 443B |
| Net Debt | 7.69B 6.7B 6.34B 5.76B 10.76B 737B 10.81B 75.51B 29.2B 374B 28.89B 28.25B 1,198B | 9.44B 8.22B 7.78B 7.07B 13.2B 904B 13.27B 92.65B 35.83B 459B 35.45B 34.66B 1,470B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/09/26 | US$309.41 | -2.85% | 1,098,496 |
| 16/09/26 | US$318.50 | -1.48% | 931,141 |
| 15/09/26 | US$323.29 | -0.90% | 913,496 |
| 14/09/26 | US$326.23 | +1.45% | 1,063,973 |
| 11/09/26 | US$321.57 | +0.19% | 844,056 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
